Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 884300

Perkins Capital Management Inc

Wealth managerFiled 2026-07-24 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$133.0M
Reported positions
79
Top holdings a year, 3 yrs
+15.6%
Assets under management
$147.8M

Perkins Capital Management Inc is a wealth manager that reported 79 positions worth $133.0M in its Q2 2026 13F, filed 2026-07-24. Its largest holdings were Natera Inc (NTRA, 8.3%), Eli Lilly & Co (LLY, 7.8%), Advanced Micro Devices Inc (AMD, 6.1%). A portfolio copying its top holdings returned 15.6% a year over the last 3 years, against 20.4% for the S&P 500.

Perkins Capital Management Inc holdings largest 50 of 79 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Perkins Capital Management Inc 13F holdings
Stock% of 13F valueShare changeReported value
NTRANatera Inc8.3%-8.3%$11.0M
LLYEli Lilly & Co7.8%-1.7%$10.4M
AMDAdvanced Micro Devices Inc6.1%-10.3%$8.1M
BFLYButterfly Network Inc5.5%-6.8%$7.3M
AXGNAxogen Inc5.1%-12.4%$6.8M
INUVInuvo Inc4.9%-11.6%$6.5M
QUIKQuicklogic Corp3.9%-16.0%$5.1M
IDXXIdexx Labs Inc3.8%+0.0%$5.1M
BLZEBackblaze Inc3.7%-8.9%$4.9M
MSFTMicrosoft Corp3.1%-2.1%$4.2M
VCYTVeracyte Inc2.6%-20.4%$3.5M
OOMAOoma Inc2.6%-2.4%$3.4M
PSNLPersonalis Inc2.4%+0.0%$3.2M
CYRXCryoport Inc2.4%-1.6%$3.1M
CIENCiena Corp2.3%+0.0%$3.1M
LMATLemaitre Vascular Inc1.8%-1.9%$2.4M
MGNIMagnite Inc1.4%-17.3%$1.9M
ABTAbbott Laboratories1.4%-1.9%$1.8M
USIOUsio Inc1.3%-0.2%$1.7M
ONDSOndas Inc1.2%-0.2%$1.7M
NEONeogenomics Inc1.2%-16.9%$1.6M
PERIPerion Network, Ltd.1.2%+5.3%$1.6M
NEOGNeogen Corp1.2%-0.3%$1.6M
CXDOExpand Energy Corp1.2%+9.2%$1.6M
ATECAlphatec Hldgs Inc1.1%+1.9%$1.5M
ABBVAbbvie Inc1.0%-0.7%$1.3M
CREXCreative Realities Inc0.9%—$1.2M
LUCDLucid Diagnostics Inc0.9%-0.1%$1.2M
CDXSCodexis Inc0.9%-0.3%$1.2M
ZETAZeta Global Holdings Corp0.8%+0.0%$1.1M
TLSITrisalus Life Sciences Inc0.8%+2.2%$1.1M
TELATela Bio Inc0.8%-3.1%$1.0M
BDSXBiodesix Inc0.8%-0.4%$1.0M
SPAISafe Pro Group Inc0.8%-0.3%$998K
MRKMerck & Co Inc0.7%-3.2%$964K
GILDGilead Sciences Inc0.7%+0.0%$912K
VTRSViatris Inc0.6%-1.9%$855K
PFEPfizer Inc0.6%-6.0%$813K
BKSYBlacksky Technology Inc0.6%+0.0%$803K
AAPLApple Inc0.6%+0.0%$767K
PROFProfound Med Corp0.6%+0.0%$760K
USBUS Bancorp0.6%-1.6%$746K
NMTCNeuroone Med Technologies Co0.6%—$744K
VIDAVida Global Inc0.5%—$700K
TGTTarget Corp0.5%—$620K
OWLTOwlet Inc0.5%—$611K
ELWTElauwit Connection Inc0.5%—$598K
MDXHMdxhealth SA0.4%-4.4%$580K
STXSeagate Technology Hldngs Pl0.4%—$507K
ATRCAtriCure, Inc.0.4%-33.0%$490K

What Perkins Capital Management Inc bought and sold in Q2 2026, against Q1 2026.

New positions

Q1 2026's filing was too long to tell new positions apart.

Added to

Reduced

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+39.1% /yr
S&P 500 +20.1%
3 years
+15.6% /yr
S&P 500 +20.4%
5 years
+0.6% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$133.0M79
Q1 2026$106.7M86
Q4 2025$125.9M91
Q3 2025$113.5M83
Q2 2025$99.5M83
Q1 2025$94.8M82
Q4 2024$112.7M81
Q3 2024$106.6M84
Q2 2024$106.1M88
Q1 2024$119.9M90
Q4 2023$117.1M92
Q3 2023$100.9M98

Questions about Perkins Capital Management Inc's portfolio

What stocks does Perkins Capital Management Inc own?

Perkins Capital Management Inc's latest 13F, for Q2 2026 and filed Jul 24, 2026, lists 79 positions worth $133.0M. The largest are Natera Inc (NTRA) at 8.3%, Eli Lilly & Co (LLY) at 7.8%, Advanced Micro Devices Inc (AMD) at 6.1%, Butterfly Network Inc (BFLY) at 5.5% and Axogen Inc (AXGN) at 5.1%.

What did Perkins Capital Management Inc buy last quarter?

In Q2 2026, Perkins Capital Management Inc added Expand Energy Corp (CXDO) (+9.2% shares) and Perion Network, Ltd. (PERI) (+5.3% shares), compared with its Q1 2026 filing.

What did Perkins Capital Management Inc sell last quarter?

In Q2 2026, Perkins Capital Management Inc cut from its top 50 Inogen Inc (INGN), cut from its top 50 Neuroone Med Technologies Co (NMTC), cut from its top 50 Elutia Inc (ELUT), cut from its top 50 Cps Technologies Corp (CPSH), cut from its top 50 Skywater Technology Inc (SKYT), AtriCure, Inc. (ATRC) (-33.0% shares), Veracyte Inc (VCYT) (-20.4% shares) and Magnite Inc (MGNI) (-17.3% shares), compared with its Q1 2026 filing.

How has Perkins Capital Management Inc's portfolio performed?

A portfolio copying Perkins Capital Management Inc's 20 largest 13F holdings each quarter, from the day each filing was public, returned +15.6% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +39.1% against +20.1%. Over 5 years: +0.6% a year against +11.6%.

When is Perkins Capital Management Inc's next 13F filing due?

13F filings are due 45 days after each quarter ends. Perkins Capital Management Inc's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.

How much money does Perkins Capital Management Inc manage?

Perkins Capital Management Inc reported $147.8M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $133.0M.